SciELO - Scientific Electronic Library Online

vol.6 issue2Average Cost Study Services in the National Hospital. 2009/10 Year author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista del Nacional (Itauguá)

Print version ISSN 2072-8174


REAL APARICIO, Chantal Marie; ARIAS YRAZUSTA, Patricia Abigail  and  SAMUDIO, Gloria. Use of colistin in Pediatrics. Rev. Nac. (Itauguá) [online]. 2014, vol.6, n.2, pp.8-15. ISSN 2072-8174.

Background: Colistin is an antibiotic of recent reintroduction in the treatment of multiresistant germs. Objective: To describe the clinical indications and the results with the use of colistin. Material and methods: We conducted a retrospective observational study in the Department of Pediatrics, National Hospital, in children treated with colistin between 2011 and 2013. Results: We included 28 patients. The most frequent comorbidities were congenital heart disease (10%), severe malnutrition (10%) and chronic renal failure (10%). The most frequent diagnosis were infections associated with health care (50%). The indication was empirical in 61%. Eleven bacterial isolates were performed, predominantly Acinetobacter baumannii (63%). Isolation sites were urine (27%), blood (18%) and tracheal secretion (18%). There were multidrug resistance in 10 of the 11 isolations (91%). Urea increased by 78% and creatinine in 57%. At discharge, most were in good condition (82%).Conclusions: The most frequent clinical indication for colistin administration were infections associated with health care (50%). The most frequent agent was Acinetobacter baumannii. The predominant toxicity was nephrotoxicity. The status at discharge was satisfactory in most cases.

Keywords : colistin; multidrug resistance to antibiotics; Acinetobacter baumannii; infections associated with health care.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License